DATABASE EUDRACT [Online] 24 April 2015 'Open label trial to evaluate the tolerability of a combination therapy consisting of GAD-alun (Diamyd), etanercept and vitamin D in children and adolescents newly diagnosed with type 1 diabetes', XP055363353 Retrieved from CLINICAL TRIALS REGISTER Database accession no. 2014-001323-76 (B1)

WO-A2-95/07992 (B1)

IVAN C GERLING ET AL: "The Thymus as a Site for Evaluating the Potency of Candidate [beta] Cell Autoantigens in NOD Mice", JOURNAL OF AUTOIMMUNITY, vol. 7, no. 6, 1 December 1994 (1994-12-01), pages 851-858, XP055434921, DOI: 10.1006/jaut.1994.1068 (B1)

JEAN-FRANÇOIS BACH ET AL: "Tolerance to Islet Autoantigens in Type 1 Diabetes", ANNU. REV. IMMUNOL, vol. 19, 1 April 2001 (2001-04-01), pages 131-161, XP055434511, England ISBN: 978-0-7817-2058-8 (B1)

JIDE TIAN ET AL: "Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted ß-Cells in Diabetic NOD Mice", PLOS ONE, vol. 6, no. 9, 22 September 2011 (2011-09-22), page e25337, XP055434119, DOI: 10.1371/journal.pone.0025337 (B1)

JOHNNY LUDVIGSSON: "The latest pharmacotherapy options for type 1 diabetes", EXPERT OPINION ON PHARMACOTHERAPY, vol. 15, no. 1, 30 November 2013 (2013-11-30), pages 37-49, XP055434033, LONDON, UK ISSN: 1465-6566, DOI: 10.1517/14656566.2014.855197 (B1)

LUDVIGSSON J.: 'Novel therapies in the managemant of type I diabetes mellitus' PANMINERVA MEDICA vol. 54, no. 4, 2012, pages 257 - 270, XP008185339 (B1)

MARVIN LIN ET AL: "Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 40, no. 8, 10 June 2010 (2010-06-10), pages 2277-2288, XP055434122, ISSN: 0014-2980, DOI: 10.1002/eji.200940094 (B1)

PRESS RELEASE: 'Ny klinisk studie med Diamyds diabetesvaccin' WEDNESDAY 30 January 2013, pages 1 - 2, XP055362420 Retrieved from the Internet: <URL:http://www.diamyd.com/docs/pressClip.a spx?section=investor &ClipID=738265> (B1)

S. ROBERT ET AL: "Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice", DIABETES, vol. 63, no. 8, 27 March 2014 (2014-03-27) , pages 2876-2887, XP055351010, US ISSN: 0012-1797, DOI: 10.2337/db13-1236 (B1)

TISCH R ET AL: "IMMUNE RESPONSE TO GLUTAMIC ACID DECARBOXYLASE CORRELATES WITH INSULITIS IN NON-OBESE DIABETIC MICE", NATURE, MACMILLAN JOURNALS LTD., ETC, vol. 366, 4 November 1993 (1993-11-04), pages 72-75, XP002909567, ISSN: 0028-0836, DOI: 10.1038/366072A0 (B1)

US-A1- 2002 107 210 (B1)

WO-A1-97/12034 (B1)

WO-A2-2005/102374 (B1)

WO-A2-2008/129426 (B1)

DATABASE EUDRACT [Online] 25 July 2012 'Pilot trial to preserve residual insulin secretion in children and adolescents with recent onset Type 1 diabetes by using GAD- antigen (Diamyd) therapy in combination with vitamin D and ibuprofen', XP055363340 Retrieved from CLINICAL TRIALS REGISTER Database accession no. 2012-003251-11 (B1)